Adverse Reaction and Immunogenicity Induced by Freeze-dried Live Attenuated Hepatitis A Vaccine
Tang Quan
Abstract
Tang Quan
Abstract
Objective To observe the adverse reaction and immunogenicity induced by freeze-dried live attenuated hepatitis A(HA)vaccine.Methods A random and open clinical trial was performed in children at more than 18 months of age,who were uninoculated with HA vaccine,and adults at 18~35 years of age in Yancheng City,Jiangsu Province,China.All the subjects were inoculated with a single dose of freeze-dried live attenuated HA vaccine and observed for immediate reactions within 30 min as well as local and systemic reactions 24,48 and 72 h after inoculation.The serum samples were collected 30 d after inoculation for evaluation of immunogenicity.Results No local reactions were observed in all the 562 subjects,while mild fever in 35 subjects(6.23%).Of the 471 subjects observed for immunogenicity of vaccine,the positive rates of anti-HAV and protective antibody were 99.8%and 96.4%respectively,and the GMC of anti-HAV was 527.4 mIU/ml,which increased by 30.3 folds compared with that before immunization.The positive rate of protective antibodies in children and adults after immunization were 97.0%and 95.9%,while the GMCs of anti-HAV were 84.1 and 2 119.1 mIU/ml,respectively,which showed significant difference with those before immunization.The positive rates of anti-HAV and protective antibody and GMCs of anti-HAV of 277 susceptible subjects after immunization were 99.6%, 93.9%and 92.6 mIU/ml respectively.However,the antibody positive rate of susceptible children after immunization was significantly higher,while the GMC of anti-HAV was significantly lower than that of susceptible adults.Conclusion Domestic freeze-dried live attenuated HA vaccine induced mild adverse reaction but good immunogenicity,which was worthy of popularization.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the adverse reaction and immunogenicity induced by freeze-dried live attenuated hepatitis A(HA)vaccine.Methods A random and open clinical trial was performed in children at more than 18 months of age,who were uninoculated with HA vaccine,and adults at 18~35 years of age in Yancheng City,Jiangsu Province,China.All the subjects were inoculated with a single dose of freeze-dried live attenuated HA vaccine and observed for immediate reactions within 30 min as well as local and systemic reactions 24,48 and 72 h after inoculation.The serum samples were collected 30 d after inoculation for evaluation of immunogenicity.Results No local reactions were observed in all the 562 subjects,while mild fever in 35 subjects(6.23%).Of the 471 subjects observed for immunogenicity of vaccine,the positive rates of anti-HAV and protective antibody were 99.8%and 96.4%respectively,and the GMC of anti-HAV was 527.4 mIU/ml,which increased by 30.3 folds compared with that before immunization.The positive rate of protective antibodies in children and adults after immunization were 97.0%and 95.9%,while the GMCs of anti-HAV were 84.1 and 2 119.1 mIU/ml,respectively,which showed significant difference with those before immunization.The positive rates of anti-HAV and protective antibody and GMCs of anti-HAV of 277 susceptible subjects after immunization were 99.6%, 93.9%and 92.6 mIU/ml respectively.However,the antibody positive rate of susceptible children after immunization was significantly higher,while the GMC of anti-HAV was significantly lower than that of susceptible adults.Conclusion Domestic freeze-dried live attenuated HA vaccine induced mild adverse reaction but good immunogenicity,which was worthy of popularization.
Key concepts: Immunogenicity, Immunization, Hepatitis A vaccine, Medicine, Antibody, Inoculation, Hepatitis A, Vaccination